Stay updated on Tagraxofusp in Secondary AML Clinical Trial

Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history page. The prior notices about government funding and operating status (v3.4.1) were removed.
    Difference
    0.6%
    Check dated 2026-02-11T12:38:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding notice banner was added. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-04T10:19:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history page now displays a glossary toggle and color-coded highlights for additions and deletions, along with revision details (v3.4.0) and No FEAR Act data notes.
    Difference
    1%
    Check dated 2026-01-28T05:39:26.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.3 to v3.3.4. No study data or functionality were affected.
    Difference
    0.1%
    Check dated 2026-01-14T03:18:54.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The TAGALONG trial record was updated to correct the study name from Azaxitadine to Azacitidine. The Study Status and Study Identification sections were added/updated with entries dated 2025-12-29 and 2025-12-31.
    Difference
    0.5%
    Check dated 2026-01-07T01:37:46.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added Study Description and Study Status entries to the record history (dated 2025-12-17) with Revision: v3.3.3. Removed the HHS Vulnerability Disclosure footer link.
    Difference
    0.6%
    Check dated 2025-12-23T21:08:12.000Z thumbnail image

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.